10 Stocks Moving In Tuesday's Pre-Market Session

Gainers

Celator Pharmaceuticals Inc CPXX shares gained 447.62 percent to $9.20 in pre-market trading following announcement Monday of positive results in Phase 3 trial for Vyxeos in patients with high risk acute myeloid leukemia.

Solazyme Inc SZYM shares rose 33.68 percent to $2.54 in pre-market trading following the announcement of the company's fourth quarter results. The micro-cap renewable oils and bioproducts producer delivered adjusted loss of $(0.32) per share, on revenue of $10.39 million

Outerwall Inc OUTR shares gained 13.41 percent to $39.00 in pre-market trading following news for investors the company has begun the process of exploring strategic and financial alternatives. Outerwall's Board also announced the raising of the company's quarterly dividend from $0.30 to $0.60 per share.

Videocon d2h Ltd - ADR VDTH shares rose 9.81 percent to $7.50 in pre-market trading after gaining 4.12 percent on Monday.

RetailMeNot Inc SALE rose 8.40 percent to $8.65 in pre-market trading after dropping 2.68 percent on Monday.

Find out what's going on in today's market and bring any questions you have to Benzinga's PreMarket Prep.

Losers

Immunomedics, Inc. IMMU shares fell 15.09 percent to $2.25 in pre-market trading after announcing it is terminating its Phase 3 PANCRIT-1 trial with yttrium-90-labeled (90Y) clivatuzumab tetraxetan in patients with metastatic pancreatic cancer who had received at least two prior therapies, one of which must have been a gemcitabine-containing regimen.

Valeant Pharmaceuticals Intl Inc VRX shares fell 14.96 percent to $58.68 in pre-market trading after the company reported downbeat Q4 earnings and lowered its full-year outlook.

Alere Inc ALR shares fell 8.88 percent to $48.75 in pre-market trading following a new delay in 10K filing and announcement of subpoena from the U.S. Department of Justice.

Zynerba Pharmaceuticals Inc ZYNE shares fell 3.71 percent to $20.25 in pre-market trading after surging 149.17 percent on Monday.

Momo Inc (ADR) MOMO shares fell 3.50 percent to $12.70 in pre-market trading. Momo reported Q4 non-GAAP diluted earnings of $0.06 per ADS on revenue of $39.5 million.